Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

JOSAMYCIN CRS (150 MG)

JOSAMYCIN CRS (150 MG)

16846-24-5

DISCOVER
JOSAMYCIN PROPIONATE CRS (150MG)

JOSAMYCIN PROPIONATE CRS (150MG)

31674-19-8

DISCOVER
ESTRADIOL VALERATE CRS (120 MG)

ESTRADIOL VALERATE CRS (120 MG)

979-32-8

DISCOVER
LEVAMISOLE HYDROCHLORIDE FOR SYSTEM SUITABILITY CRS (15 MG)

LEVAMISOLE HYDROCHLORIDE FOR SYSTEM SUITABILITY CRS (15 MG)

16595-80-5

DISCOVER
LEVAMISOLE - REFERENCE SPECTRUM (N/A)

LEVAMISOLE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
AMLODIPINE BESILATE CRS (150 MG)

AMLODIPINE BESILATE CRS (150 MG)

111470-99-6

DISCOVER
TRIAMCINOLONE IMPURITY C CRS (10 MG)

TRIAMCINOLONE IMPURITY C CRS (10 MG)

NA

DISCOVER
ERYSIPELAS ELISA COATING ANTIGEN BRP (0.4 MG)

ERYSIPELAS ELISA COATING ANTIGEN BRP (0.4 MG)

NA

DISCOVER
EQUILIN CRS (20 MG)

EQUILIN CRS (20 MG)

474-86-2

DISCOVER
17 ALPHA-DIHYDROEQUILIN CRS (10 MG)

17 ALPHA-DIHYDROEQUILIN CRS (10 MG)

NA

DISCOVER
ALPROSTADIL CRS (25 MG)

ALPROSTADIL CRS (25 MG)

745-65-3

DISCOVER
Acamprosate calcium - reference spectrum, Qty : n/a

Acamprosate calcium - reference spectrum, Qty : n/a

NA

DISCOVER